John Capelle, MD
Orthopaedic Surgery · Supply, NCNPI 1528419579
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Arthrex at 43.9% of the total. 2023 is the largest year on record at $1,243, more than ten times the $40 reported in 2020. That places this record below the midpoint for orthopaedic surgery clinicians in NC, where the typical reported total is $4,547.
Across 21 payments — averaging $67.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$627
- Medical Device Business Services, Inc.$316
- Integra Lifesciences Corporation$168
- Acumed LLC$167
- Medacta USA, Inc.$110
- Elite Orthopedics, LLC$40
What the payments were for
- Travel & lodging$46833%
- Food & beverage$64345%
- Education$31622%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 12 | $627 |
| Medical Device Business Services, Inc. | 1 | $316 |
| Integra Lifesciences Corporation | 2 | $168 |
| Acumed LLC | 4 | $167 |
| Medacta USA, Inc. | 1 | $110 |
| Elite Orthopedics, LLC | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,427 in reported general payments places this provider in the 25th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 340 | $786 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 54 | $349 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $303 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $70 |
| Celecoxib | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Supply
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.